Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Detection and Outcomes in Patients With Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAPI PET Imaging

NCT07285993 is registered in ClinicalTrials.gov with Randy Yeh as lead sponsor.

NCT NCT07285993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07285993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Detection and Outcomes in Patients With Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAPI PET Imaging
Lead sponsor
Randy Yeh
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 30, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic invasive lobular breast cancer